The New York Entrepreneur

Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up

Read Time:7 Second

Alzheimer’s drug Leqembi brought in in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Kering shares sink 9% after profit warning on declining Gucci sales
Next post Biogen first-quarter profit tops estimates as Alzheimer’s drug uptake improves